May 22, 2015 – In June, Bill Brydges, CEO of Brydges Group, and Susan Stipa, president of McDAY, will travel together to visit Amgen, Novartis, Biogen Idec, Pfizer, Genzyme, LotusWorks, and A/Z Corporation to discuss a variety of new products and solutions with senior executives in manufacturing and operations.
McDAY and The Brydges Group often collaborate with clients together, offering marketing and strategic planning. This could include the development of US market entry strategies for overseas pharmaceutical industry clients, marketing, website and collateral production, showcasing innovative technologies to senior executives in the pharma/biotech industry or simply making introductions on behalf of mutual clients. The visit will also include a stop at the Boston headquarters of Enterprise Ireland. McDAY assists EI with Irish companies interested in a market analysis of the biopharmaceutical market with an eye towards US market entry.